These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7507748)

  • 21. [Immunohistochemistry in breast pathology: differential diagnosis of epithelial breast lesions].
    Böcker W; Hungermann D; Weigel S; Tio J; Decker T
    Pathologe; 2009 Feb; 30(1):13-9. PubMed ID: 19184023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fortuitous diagnosis in a uterine leiomyoma of metastatic lobular carcinoma of the breast.
    Liebmann RD; Jones KD; Hamid R; Lapsley M
    Histopathology; 1998 Jun; 32(6):577-8. PubMed ID: 9675605
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lobular carcinoma in situ in sclerosing adenosis.
    Jung WH; Noh TW; Kim HJ; Kim DY; Lee HD; Oh KK
    Yonsei Med J; 2000 Apr; 41(2):293-7. PubMed ID: 10817035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent data on lobular neoplasia of the breast: the pathologist's opinion].
    Bibeau F; Borrelly C; Chateau MC; Saingra B; Lemanski C; Masson B; Rouanet P; Gutowski M
    Bull Cancer; 2005 May; 92(5):453-8. PubMed ID: 15932809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
    Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive breast carcinoma arising in microglandular adenosis: a case report and review of the literature.
    Shui R; Yang W
    Breast J; 2009; 15(6):653-6. PubMed ID: 19824997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.
    Maluf HM; Swanson PE; Koerner FC
    Am J Surg Pathol; 2001 Feb; 25(2):237-44. PubMed ID: 11176073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM
    Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A confusing cancer.
    Health News; 1998 Aug; 4(10):1-2. PubMed ID: 9708039
    [No Abstract]   [Full Text] [Related]  

  • 32. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
    Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Atypical ductal and lobular hyperplasia of the breast].
    Bricou A; Delpech Y; Barranger E
    Gynecol Obstet Fertil; 2009 Oct; 37(10):814-9. PubMed ID: 19766043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical study in breast carcinoma. S100-protein positive cells and neuroendocrine differentiation.
    Zółtowska A; Moszkowska G; Zamorska B; Roszkiewicz A
    Arch Immunol Ther Exp (Warsz); 1996; 44(4):271-7. PubMed ID: 9017169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectral morphometric characterization of breast carcinoma cells.
    Barshack I; Kopolovic J; Malik Z; Rothmann C
    Br J Cancer; 1999 Mar; 79(9-10):1613-9. PubMed ID: 10188915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness and limitations of E-cadherin and β-catenin in the classification of breast carcinomas in situ with mixed pattern.
    Gomes DS; Porto SS; Rocha RM; Gobbi H
    Diagn Pathol; 2013 Jul; 8():114. PubMed ID: 23837653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.